This review provides a comprehensive and up-to-date overview of point-of-care (POC)
devices most commonly used for coagulation analyses in the acute settings. Fast and …

Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF).
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …

The purpose of the currents study was to enhance bioavailability of rivaroxaban (RXB) and
reduce the food effect. RXB loaded PLGA nanoparticles (RXB-PLGA-NPs) were prepared by …

Mechanical properties have been extensively studied in pure elastic or viscous materials;
however, most biomaterials possess both physical properties in a viscoelastic component …

Background Thromboembolic events are a common complicated health problem. Although
anticoagulants have several positive effects on these conditions, they also have several …

Background: Cardioembolic stroke (CES), generally known as the most severe subtype of
ischemic stroke, is related to many factors, including diabetes mellitus (DM), hypertension …

Atrial fibrillation (AF) often coexists with chronic kidney disease (CKD), which confer to the
patient a higher risk of both thromboembolic and hemorrhagic events. Oral anticoagulation …

Approval of direct‐acting oral anticoagulants (DOACs) for stroke prevention in atrial
fibrillation (AF) was an important milestone, providing a wider range of treatment options and …

Patients requiring low-dose warfarin are more likely to suffer bleeding due to overdose. The
goal of this work is to improve the feedforward neural network model's precision in predicting …

Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …